HDL Therapeutics. Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Reverse Merger
  • (Cancelled)

  • Latest Deal Amount
  • $480M

  • Investors
  • 1

HDL Therapeutics. General Information

Description

Operator of a biotechnology company intended to fight heart disease. The company helps to fill a critical gap in treatment options for patients with severe atherosclerotic disease, enabling physicians to reduce coronary atheroma in a rare cardiovascular disease.

Contact Information

Website
www.hdltherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 601 21st Street
  • Suite 300
  • Vero Beach, FL 32960
  • United States
+1 (772)
Primary Industry
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 601 21st Street
  • Suite 300
  • Vero Beach, FL 32960
  • United States
+1 (772)

HDL Therapeutics. Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HDL Therapeutics. Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Reverse Merger 24-Apr-2023 $480M Cancelled Pre-Clinical Trials
7. Later Stage VC 11-Jul-2023 Completed Pre-Clinical Trials
6. Accelerator/Incubator Completed Pre-Clinical Trials
5. Later Stage VC (Series E) 04-Mar-2021 Completed Pre-Clinical Trials
4. Later Stage VC (Series D) 03-Oct-2019 Completed Pre-Clinical Trials
3. Later Stage VC (Series C) 10-May-2017 Completed Pre-Clinical Trials
2. Early Stage VC (Series B) 31-Dec-2014 $2.04M $2.97M Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 13-Feb-2013 $925K $925K Completed Pre-Clinical Trials
To view HDL Therapeutics.’s complete valuation and funding history, request access »

HDL Therapeutics. Patents

  • 77

    Total Documents Applications and Grants

  • Total Patents Families

  • 23

    Granted

  • 26

    Pending

  • Expiring in next 12 mo

HDL Therapeutics. Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210283201-A1 Systems and methods for treating patients infected with sars-cov-2 Inactive 06-Mar-2020
AU-2019389048-A1 Methods for treating lipid-related diseases including xanthomas, carotid artery stenoses, and cerebral atherosclerosis Pending 30-Nov-2018
EP-3886871-A1 Methods for treating lipid-related diseases including xanthomas, carotid artery stenoses, and cerebral atherosclerosis Inactive 30-Nov-2018
CA-3121552-A1 Methods for treating lipid-related diseases including xanthomas, carotid artery stenoses, and cerebral atherosclerosis Pending 30-Nov-2018
JP-2022510976-A Treatment of lipid-related diseases including xanthoma, carotid artery stenosis, and cerebrovascular atherosclerosis Pending 30-Nov-2018 A61P3/06
To view HDL Therapeutics.’s complete patent history, request access »

HDL Therapeutics. Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HDL Therapeutics. Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Massachusetts Biomedical Initiatives Accelerator/Incubator
To view HDL Therapeutics.’s complete investors history, request access »

Ready to get started?

Request a free trial

HDL Therapeutics. FAQs

  • When was HDL Therapeutics. founded?

    HDL Therapeutics. was founded in 2013.

  • Where is HDL Therapeutics. headquartered?

    HDL Therapeutics. is headquartered in Vero Beach, FL.

  • What is the size of HDL Therapeutics.?

    HDL Therapeutics. has 6 total employees.

  • What industry is HDL Therapeutics. in?

    HDL Therapeutics.’s primary industry is Biotechnology.

  • Is HDL Therapeutics. a private or public company?

    HDL Therapeutics. is a Private company.

  • What is HDL Therapeutics.’s current revenue?

    The current revenue for HDL Therapeutics. is .

  • How much funding has HDL Therapeutics. raised over time?

    HDL Therapeutics. has raised $17.8M.

  • Who are HDL Therapeutics.’s investors?

    Massachusetts Biomedical Initiatives has invested in HDL Therapeutics..

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »